ABSTRACT

Benign Prostatic Hyperplasia (BPH) is one of the most prevalent medical conditions affecting the geriatric male population. The non-malignant enlargement of the prostate gland can lead to a range of clinical symptoms, including difficulty in voiding, urinary retention, and increased urinary frequency. The severity of symptoms often varies based on the degree of prostate enlargement. The International Prostate Symptom Score (IPSS) remains the gold standard for initial clinical assessment of BPH. However, recent advancements have introduced a variety of new diagnostic tools that enhance understanding and precision in diagnosing prostate hyperplasia. Over the past few years, BPH management has evolved significantly, with both medical and surgical interventions aimed at improving the patient's quality of life and reducing disease burden. Tailored pharmacological treatments, including alpha-blockers and 5-alpha- reductase inhibitors, along with minimally invasive surgical techniques, provide effective options to manage this condition, ultimately alleviating symptoms and improving long-term outcomes. This review highlights the importance of early diagnosis and personalized treatment approaches to effectively manage BPH and improve patient outcomes. Keywords: Benign Prostatic Hyperplasia, Geriatric, International Prostatic Symptom Score
Publication date: 01/02/2026

https://ijbpas.com/pdf/2026/February/MS_IJBPAS_2026_9818.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2026/15.2.9818